Sophia Genetics

SOPHiA GENETICS Announces Pricing of Initial Public Offering

BOSTON and LAUSANNE, Switzerland, July 22, 2021 — SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the pricing of its initial public offering of 13,000,000 ordinary shares at a price of $18 per share. The gross proceeds from the offering, before deducting underwriting …

SOPHiA GENETICS Announces Pricing of Initial Public Offering Read More »

Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships

CHICAGO – Sophia Genetics on Friday executed an initial public offering, from which it expects to raise approximately $234 million in gross proceeds before underwriting discounts, commissions, and other expenses. The Swiss-American bioinformatics company expects the IPO to close July 27. Sophia, which has twin headquarters in Saint-Sulpice, Switzerland and Boston, is selling 13 million common …

Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships Read More »

SOPHiA GENETICS Announces Filing of Registration Statement for Proposed Initial Public Offering

BOSTON and LAUSANNE, Switzerland, July 2, 2021 — SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares. The number of …

SOPHiA GENETICS Announces Filing of Registration Statement for Proposed Initial Public Offering Read More »

How Alan Turing’s work revolutionized medical research

Sometimes referred to as the father of modern computing, Alan Turing planted the roots of artificial intelligence and machine learning. The British mathematician deciphered cryptic messages during World War II, helping the Allies win. Yet, he was considered a criminal for his homosexuality. And because much of his work was classified, he did not receive …

How Alan Turing’s work revolutionized medical research Read More »

Mutational hotspot in the SARS-CoV-2 Spike protein N-terminal domain conferring immune escape potential

Our team at SOPHiA GENETICS continues to work to help advance the efforts of SARS-CoV-2 surveillance and research. During the first stages of the pandemic, we leveraged our experience in NGS and developed a robust solution for full-genome analysis of SARS-CoV-2 to identify circulating and emerging strains. Recently, our genomic experts have worked with international partners …

Mutational hotspot in the SARS-CoV-2 Spike protein N-terminal domain conferring immune escape potential Read More »

Three steps forward in efficient myeloid biomarker learning

More than six people die every hour in the US from a blood cancer. Solutions can’t come fast enough for those who suffer with these cancers all around the world. Fortunately, researchers studying blood diseases have experienced rapid advances in their capabilities to develop and test effective therapies with some extremely significant advancements. READ MORE